Rakovina Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.59	0.3	1.31	0.44	0.9	2.81
Cash & Short-Term Investments	0.59	0.3	1.31	0.44	0.9	2.81
Cash Growth	672.77%	-77.24%	200.87%	-51.35%	-68.10%	40164757.14%
Accounts Receivable	0.04	0.06	0.08	0.02	0.01	0.07
Total Trade Receivables	0.04	0.06	0.08	0.02	0.01	0.07
Other Current Assets	0.26	0.45	0.87	0.18	0.16	0.19
Total Current Assets	0.89	0.8	2.26	0.63	1.07	3.07
Other Intangible Assets	3.31	3.44	3.98	4.52	5.05	5.59
Total Assets	4.2	4.24	6.24	5.15	6.12	8.66
Accounts Payable	1.6	1.3	0.51	0.15	0.11	0.11
Short-Term Debt	-	1.45	1.42	-	-	-
Other Current Liabilities	0.02	0.2	0.02	-	-	-
Total Current Liabilities	1.62	2.95	1.94	0.15	0.11	0.11
Long-Term Debt	3.01	1.15	-	1.33	-	-
Other Long-Term Liabilities	0.13	-	-	-	-	-
Total Long-Term Liabilities	3.13	1.15	-	1.33	-	-
Total Liabilities	4.75	4.1	1.94	1.49	0.11	0.11
Common Stock	19.24	18.75	16.45	13.6	13.58	13.57
Additional Paid-in Capital	5.56	5.07	2.85	0.99	0.75	0.49
Retained Earnings	-25.35	-23.68	-15	-10.93	-8.31	-5.52
Shareholders' Equity	-0.56	0.14	4.3	3.66	6.01	8.54
Total Liabilities & Equity	4.2	4.24	6.24	5.15	6.12	8.66
Total Debt	3.01	2.6	1.42	1.33	0	0
Net Cash (Debt)	-2.42	-2.3	-0.11	-0.9	0.9	2.81
Net Cash Growth	-	-	-	-	-68.10%	40164757.14%
Net Cash Per Share	-0.12	-0.13	-0.01	-0.13	0.13	0.52
Book Value	-0.56	0.14	4.3	3.66	6.01	8.54
Book Value Per Share	-0.03	0.01	0.52	0.52	0.86	1.59
Tangible Book Value	-3.86	-3.3	0.32	-0.86	0.96	2.96
Tangible Book Value Per Share	-0.19	-0.18	0.04	-0.12	0.14	0.55